Search

Your search keyword '"Chindris, Ana‐Maria"' showing total 32 results
Start Over Author "Chindris, Ana‐Maria"
32 results on '"Chindris, Ana‐Maria"'

10. Continuous Glucose Monitoring for Patients with COVID-19 Pneumonia: Initial Experience at a Tertiary Care Center

Author

Dumitrascu, Adrian G., primary, Perry, Michelle F., additional, Boone, Rebecca J., additional, Guzman, Maria P., additional, Chirila, Razvan M., additional, McNally, Allyson W., additional, Colibaseanu, Dorin T., additional, Meek, Shon E., additional, Ball, Colleen T., additional, White, Launia J., additional, and Chindris, Ana-Maria, additional

Published
2022
Full Text
View/download PDF

15. MEN1 Mutations in Hürthle Cell (Oncocytic) Thyroid Carcinoma

Author

Kasaian, Katayoon, Chindris, Ana-Maria, Wiseman, Sam M., Mungall, Karen L., Zeng, Thomas, Tse, Kane, Schein, Jacqueline E., Rivera, Michael, Necela, Brian M., Kachergus, Jennifer M., Casler, John D., Mungall, Andrew J., Moore, Richard A., Marra, Marco A., Copland, John A., Thompson, E. Aubrey, Smallridge, Robert C., and Jones, Steven J. M.

Published
2015

16. Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid

Author

Chindris, Ana-Maria, Casler, John D., Bernet, Victor J., Rivera, Michael, Thomas, Colleen, Kachergus, Jennifer M., Necela, Brian M., Hay, Ian D., Westphal, Sydney A., Grant, Clive S., Thompson, Geoffrey B., Schlinkert, Richard T., Thompson, E. Aubrey, and Smallridge, Robert C.

Published
2015

17. RNA Sequencing Identifies Multiple Fusion Transcripts, Differentially Expressed Genes, and Reduced Expression of Immune Function Genes in BRAF (V600E) Mutant vs BRAF Wild-Type Papillary Thyroid Carcinoma

Author

Smallridge, Robert C., Chindris, Ana-Maria, Asmann, Yan W., Casler, John D., Serie, Daniel J., Reddi, Honey V., Cradic, Kendall W., Rivera, Michael, Grebe, Stefan K., Necela, Brian M., Eberhardt, Norman L., Carr, Jennifer M., McIver, Bryan, Copland, John A., and Aubrey Thompson, E.

Published
2014

20. Contributors

Author

Asp, Arnold A., primary, Barbour, Linda A., additional, Bell, Brenda K., additional, Bessesen, Daniel H., additional, Bridenstine, Mark, additional, Bright, Tamis M., additional, Brooks, Heather E., additional, Burch, Henry B., additional, Chindris, Ana-Maria, additional, Christensen, Reed S., additional, Clements, Scott A., additional, Daily, Jason, additional, Decort, Ryan M., additional, Draznin, Boris, additional, Duncan, William E., additional, Fitzpatrick, James E., additional, Frey, Col. William C., additional, Georgitis, William J., additional, Goldenberg, Gary, additional, Graybill, Sky D., additional, Grotzke, Marissa, additional, Haugen, Bryan R., additional, Hennessey, James V., additional, Hoang, Thanh D., additional, Jones, Robert E., additional, Klopper, Joshua, additional, Kohrt, Wendy M., additional, Kumar, Pratima, additional, LeMar, Homer J., additional, Levy, Elliot G., additional, McDermott, Michael T., additional, McIntyre, Robert C., additional, McIntyre, Peter Z., additional, Meek, Shon, additional, Migdal, Alexandra L., additional, Ng, Stephanie B., additional, Nuffer, Wesley, additional, Orrego, John J., additional, Patel, Samir J., additional, Piepenbrink, Roger A., additional, Piya, Anil, additional, Raeburn, Christopher D., additional, Rothman, Micol S., additional, Samuels, Mary H., additional, Sanders, Leonard R., additional, Sarapura, Virginia, additional, Schoen, Jonathan A., additional, Schroeder, Emily, additional, Schwartz, Robert S., additional, Seggelke, Stacey A., additional, Simcic, Kenneth J., additional, Slover, Robert H., additional, Smallridge, Robert C., additional, Sobel, Sandra I., additional, Thomas, Elizabeth A., additional, Travers, Sharon, additional, Trujillo, Jennifer M., additional, Vigersky, Robert A., additional, Wagler, Vanya D., additional, Low Wang, Cecilia C., additional, Weber, Katherine, additional, Wierman, Margaret E., additional, Yau, Amy A., additional, Zeitler, Philip, additional, and Zibert, Kimberly C., additional

Published
2013
Full Text
View/download PDF

22. Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer

Author

Klubo-Gwiezdzinska, Joanna, primary, Auh, Sungyoung, additional, Gershengorn, Marvin, additional, Daley, Brianna, additional, Bikas, Athanasios, additional, Burman, Kenneth, additional, Wartofsky, Leonard, additional, Urken, Mark, additional, Dewey, Eliza, additional, Smallridge, Robert, additional, Chindris, Ana-Maria, additional, and Kebebew, Electron, additional

Published
2019
Full Text
View/download PDF

30. MEN1Mutations in Hürthle Cell (Oncocytic) Thyroid Carcinoma

Author

Kasaian, Katayoon, Chindris, Ana-Maria, Wiseman, Sam M., Mungall, Karen L., Zeng, Thomas, Tse, Kane, Schein, Jacqueline E., Rivera, Michael, Necela, Brian M., Kachergus, Jennifer M., Casler, John D., Mungall, Andrew J., Moore, Richard A., Marra, Marco A., Copland, John A., Thompson, E. Aubrey, Smallridge, Robert C., and Jones, Steven J. M.

Published
2015
Full Text
View/download PDF

31. When a "Low T" Diagnosis Can Be the Clue to a More Complex Problem.

Author

Dumitrascu AG, Chindris AM, Matei C, and Chirila RM

Abstract

Male hypogonadism remains a poorly evaluated and managed clinical condition despite the availability of clinical guidelines. We present a case of a male patient diagnosed with secondary hypogonadism related to partial empty sella syndrome, whose clinical course was complicated by a hypotensive near-syncopal event. Although initial hypopituitarism symptoms could be subtle and nonspecific and could involve only one hormonal axis, a thorough evaluation of the pituitary function may identify additional deficiencies such as a subclinical chronic adrenal insufficiency that may become manifest during situations of increased physiological stress with potential life-threatening consequences., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Dumitrascu et al.)

Published
2023
Full Text
View/download PDF

32. Continuous Glucose Monitoring for Patients with COVID-19 Pneumonia: Initial Experience at a Tertiary Care Center.

Author

Dumitrascu AG, Perry MF, Boone RJ, Guzman MP, Chirila RM, McNally AW, Colibaseanu DT, Meek SE, Ball CT, White LJ, and Chindris AM

Subjects
Adult, Humans, Blood Glucose, Blood Glucose Self-Monitoring, Reproducibility of Results, Tertiary Care Centers, Insulin, Insulin, Regular, Human, COVID-19, Hyperglycemia, Diabetes Mellitus, Type 1
Abstract

Objective: Patients hospitalized with COVID-19 and hyperglycemia require frequent glucose monitoring, usually performed with glucometers. Continuous glucose monitors (CGMs) are common in the outpatient setting but not yet approved for hospital use. We evaluated CGM accuracy, safety for insulin dosing, and CGM clinical reliability in 20 adult patients hospitalized with COVID-19 and hyperglycemia., Methods: Study patients were fitted with a remotely monitored CGM. CGM values were evaluated against glucometer readings. The CGM sensor calibration was performed if necessary. CGM values were used to dose insulin, without glucometer confirmation., Results: CGM accuracy against glucometer, expressed as mean absolute relative difference (MARD), was calculated using 812 paired glucometer-CGM values. The aggregate MARD was 10.4%. For time in range and grades 1 and 2 hyperglycemia, MARD was 11.4%, 9.4%, and 9.1%, respectively, with a small variation between medical floors and intensive care units. There was no MARD correlation with mean arterial blood pressure levels, oxygen saturation, daily hemoglobin levels, and glomerular filtration rates. CGM clinical reliability was high, with 99.7% of the CGM values falling within the "safe" zones of Clarke error grid. After CGM placement, the frequency of glucometer measurements decreased from 5 to 3 and then 2 per day, reducing nurse presence in patient rooms and limiting viral exposure., Conclusion: With twice daily, on-demand calibration, the inpatient CGM use was safe for insulin dosing, decreasing the frequency of glucometer fingersticks. For glucose levels >70 mg/dL, CGMs showed adequate accuracy, without interference from vital and laboratory values., Competing Interests: Disclosure A.D. holds shares in Dexcom, Sensionics, Tandem, and Insulet. M.P. holds shares in Dexcom and Insulet. A.M. holds shares in Medtronics. The other authors have no multiplicity of interest to disclose., (Copyright © 2022 AACE. Published by Elsevier Inc. All rights reserved.)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results